Assignment

Vinge has advised Pandox in connection with a directed share issue

March 30, 2017

Vinge has advised Pandox Aktiebolag (publ) in connection with a directed share issue of 7,499,99 class B shares at a subscription price of SEK 135 per share. Through the share issue, Pandox will obtain approximately SEK 1,012 million. The subscription price was determined through an accelerated book-building process. The share issue is directed to selected Swedish and international institutional investors. The purpose of the share issue is to, in a timely and cost efficient manner, enable a capital raising to finance acquisitions and thereby increase the company’s financial flexibility and mandate for continued value creation.
 
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. The company’s shares are admitted to trading on Nasdaq Stockholm.
 
Vinge’s team primarily consisted of Jesper Schönbeck, Erik Sjöman, Nils Fredrik Dehlin, Tora Hansjons and Michaela Cronemyr.

Related

Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)

DTG operates 31 clinics and 8 dental laboratories in the Netherlands. Oral Care is a portfolio company of Axcel VI and operates a network of dental clinics in Sweden, Norway and the Netherlands. To support this expansion, Axcel VII is joining Axcel VI as a shareholder in Oral Care.
February 19, 2025

Vinge advises Gotlandsbolaget in connection with off-take agreement regarding biogas

Vinge has advised Rederiaktiebolaget Gotland (Gotlandsbolaget) in connection with the entry into of a strategic off-take agreement, which secures the long-term supply of biogas for the Gotland ferry service traffic.
February 17, 2025

Vinge advises HAKI Safety AB in connection with the acquisition of Trimtec

Trimtec is a Swedish distributor of high-tech precision equipment.
February 14, 2025